Precure, LLC selects Helix as multi-omics lab and AI tools provider
Article excerpt
Highlighted: the sentence this signal was extracted from
image: Mayo Clinic research technologist preparing cartridges for genome sequencing automation equipment. view more Mayo Clinic research technologist preparing cartridges for genome sequencing automation equipment. Credit: Mayo Clinic ROCHESTER, Minn. and SAN MATEO, Calif. - Precure, LLC today announced the selection of Helix as its multi-omic laboratory and AI tools provider supporting plans to generate comprehensive molecular data from approximately one million biospecimens and accelerate the integration of molecular insights into routine clinical care at Mayo Clinic and across health systems more broadly. Less than a week ago, Mayo Clinic announced the launch of Precure, LLC, with founding partner Thermo Fisher Scientific, to help transform how the life sciences community understands the biological changes that occur as disease develops before symptoms occur. Precure, LLC brings together clinical expertise, de-identified longitudinal health information and population-scale molecular data to accelerate the development of new approaches to care. Helix will provide both advanced AI tools for delivery of genomics into the clinic and biomarker driven research, and population scale multi-omic capability that encompasses clinical whole genome sequencing (WGS) and research grade proteome sequencing. Linked with longitudinal clinical information and high performance compute...
Keep reading with a free account
The rest of this article, and every signal for Mayo Clinic, is in your free account.